OPPM
FBIO icon

Opus Point Partners Management’s Fortress Biotech FBIO Stock Holding History

Opus Point Partners Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$865K Buy
40,903
+25,301
+162% +$595K 1.56% 14
2019
Q2 		$351K Hold
15,602
– – 0.52% 45
2019
Q1 		$417K Hold
15,602
– – 0.57% 44
2018
Q4 		$201K Hold
15,602
– – 0.44% 38
2018
Q3 		$374K Buy
+15,602
New +$499K 0.89% 37

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Opus Point Partners Management's FBIO Position: Q3 2019 in Review

Opus Point Partners Management increased its Fortress Biotech (FBIO) stake by 162% in Q3 2019, buying an estimated $595K and bringing the position to 40,903 shares worth $865K. The position accounts for 1.56% of the portfolio, ranked #14.

Opus Point Partners Management first reported a position in FBIO in Q3 2018 and has held it in 5 quarters since. 49 funds tracked by Wall St. Rank hold FBIO as of Q3 2019.

  • Opus Point Partners Management held 40,903 shares of Fortress Biotech worth $865K as of Q3 2019.
  • Opus Point Partners Management bought 25,301 Fortress Biotech shares in Q3 2019, an estimated $595K.
  • Fortress Biotech made up 1.56% of Opus Point Partners Management's portfolio in Q3 2019, its #14 holding.
  • Opus Point Partners Management first reported a position in Fortress Biotech in Q3 2018 and has held it in 5 quarters since.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.